96 related articles for article (PubMed ID: 22371626)
1. Reduced plasma eicosapentaenoic acid-arachidonic acid ratio in peripheral artery disease.
Fujihara M; Fukata M; Odashiro K; Maruyama T; Akashi K; Yokoi Y
Angiology; 2013 Feb; 64(2):112-8. PubMed ID: 22371626
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the serum eicosapentaenoic acid to arachidonic acid ratio in relation to clinical outcomes after endovascular therapy in patients with peripheral artery disease caused by femoropopliteal artery lesions.
Hishikari K; Kimura S; Yamakami Y; Kojima K; Sagawa Y; Otani H; Sugiyama T; Kuwahara T; Hikita H; Takahashi A; Isobe M
Atherosclerosis; 2015 Apr; 239(2):583-8. PubMed ID: 25733330
[TBL] [Abstract][Full Text] [Related]
3. Effects of a fish-based diet and administration of pure eicosapentaenoic acid on brachial-ankle pulse wave velocity in patients with cardiovascular risk factors.
Fukuoka Y; Nuruki N; Amiya S; Tofuku K; Aosaki S; Tsubouchi H
J Cardiol; 2014 Mar; 63(3):211-7. PubMed ID: 24080436
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Serum Eicosapentaenoic Acid to Arachidonic Acid Ratio and Atherosclerotic Risk Factors in Patients With Peripheral Artery Disease.
Nishibe T; Dardik A; Nishibe M; Kano M; Matsumoto R; Nakano Y; Maekawa K; Irikata Y; Ogino H; Ono S; Koizumi J
Vasc Endovascular Surg; 2021 Feb; 55(2):112-116. PubMed ID: 33073735
[TBL] [Abstract][Full Text] [Related]
5. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
[TBL] [Abstract][Full Text] [Related]
6. Associations With Eicosapentaenoic Acid to Arachidonic Acid Ratio and Mortality in Hospitalized Heart Failure Patients.
Watanabe S; Yoshihisa A; Kanno Y; Takiguchi M; Yokokawa T; Sato A; Miura S; Shimizu T; Abe S; Sato T; Suzuki S; Oikawa M; Sakamoto N; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
J Card Fail; 2016 Dec; 22(12):962-969. PubMed ID: 27138463
[TBL] [Abstract][Full Text] [Related]
7. The ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cancer death in a Japanese community: The Hisayama Study.
Nagata M; Hata J; Hirakawa Y; Mukai N; Yoshida D; Ohara T; Kishimoto H; Kawano H; Kitazono T; Kiyohara Y; Ninomiya T
J Epidemiol; 2017 Dec; 27(12):578-583. PubMed ID: 28669629
[TBL] [Abstract][Full Text] [Related]
8. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?
Iwamatsu K; Abe S; Nishida H; Kageyama M; Nasuno T; Sakuma M; Toyoda S; Inoue T
Hypertens Res; 2016 Apr; 39(4):272-5. PubMed ID: 26739870
[TBL] [Abstract][Full Text] [Related]
9. Comparison of eicosapentaenoic acid concentrations in plasma between patients with ischemic stroke and control subjects.
Ikeya Y; Fukuyama N; Kitajima W; Ogushi Y; Mori H
Nutrition; 2013 Jan; 29(1):127-31. PubMed ID: 23010418
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal study of the association of the eicosapentaenoic acid/arachidonic acid ratio derived from fish consumption with the serum lipid levels: a pilot study.
Tani S; Matsuo R; Matsumoto N
Heart Vessels; 2019 Jan; 34(1):189-196. PubMed ID: 30014269
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of eicosapentaenoic acid/arachidonic acid ratio (EPA/AA) in adult patients with congenital heart disease.
Kanoh M; Inai K; Shinohara T; Tomimatsu H; Nakanishi T
Heart Vessels; 2017 Dec; 32(12):1513-1522. PubMed ID: 28681101
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the serum eicosapentanoic acid-to-arachidonic acid ratio and the severity of cerebral white matter hyperintensities in older adults with memory disorder.
Nagai K; Koshiba H; Shibata S; Matsui T; Kozaki K
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():48-52. PubMed ID: 26671157
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in the ratio of eicosapentaenoic acid to arachidonic acid in an inland prefecture, Tochigi: Tochigi Ryomo EPA/AA Trial in Coronary Artery Disease (TREAT-CAD).
Kitagawa Y; Abe S; Toyoda S; Watanabe S; Ebisawa K; Murakami Y; Takahashi T; Sugimura H; Taguchi I; Inoue T
Intern Med; 2014; 53(3):177-82. PubMed ID: 24492684
[TBL] [Abstract][Full Text] [Related]
14. Screening of unrecognized peripheral arterial disease (PAD) using ankle-brachial index in high cardiovascular risk patients free from symptomatic PAD.
Mourad JJ; Cacoub P; Collet JP; Becker F; Pinel JF; Huet D; Sevestre-Pietri MA; Priollet P;
J Vasc Surg; 2009 Sep; 50(3):572-80. PubMed ID: 19560312
[TBL] [Abstract][Full Text] [Related]
15. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
[TBL] [Abstract][Full Text] [Related]
16. Ratio of eicosapentaenoic acid to arachidonic acid is a critical risk factor for acute coronary syndrome in middle-aged older patients as well as younger adult patients.
Serikawa T; Miura S; Okabe M; Hongo H; Tokutome M; Yoshikawa T; Takesue K; Adachi S; Osaka K; Matsukawa R; Yanagi D; Nozoe M; Kozai T; Hironaga K; Saku K; Yamamoto Y
J Cardiol; 2014 Jan; 63(1):35-40. PubMed ID: 23993904
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
[TBL] [Abstract][Full Text] [Related]
18. Variations in the eicosapentaenoic acid-arachidonic acid ratio associated with age in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.
Nakabayashi K; Jujo K; Furuki Y; Ishida I; Ando H; Shimizu M; Hagiwara N; Saito K
Heart Vessels; 2019 May; 34(5):755-762. PubMed ID: 30430295
[TBL] [Abstract][Full Text] [Related]
19. Relation of omega-3 fatty acid and C-reactive protein to peripheral artery disease in patients with coronary artery disease.
Sugiura T; Yoshikawa D; Ishii H; Suzuki S; Kumagai S; Inoue Y; Okumura S; Isobe S; Hayashi M; Ando H; Amano T; Murohara T
Heart Vessels; 2014 Jul; 29(4):449-55. PubMed ID: 23801460
[TBL] [Abstract][Full Text] [Related]
20. Relation of borderline peripheral arterial disease to cardiovascular disease risk.
Menke A; Muntner P; Wildman RP; Dreisbach AW; Raggi P
Am J Cardiol; 2006 Nov; 98(9):1226-30. PubMed ID: 17056334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
